2 news items
Alimera Sciences Reports Q1 Loss, Misses Revenue Estimates
ALIM
OVID
14 May 24
.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly
Alimera Announces Scientific Data Highlighting YUTIQ To Be Presented At Upcoming Association For Research In Vision And Ophthalmology And Retina World Congress Conferences
ALIM
7 May 24
Fluocinolone Acetonide Intravitreal Implant: a CALM Registry AnalysisAbout YUTIQYUTIQ is a sustained release
- Prev
- 1
- Next